TWI301763B - - Google Patents

Download PDF

Info

Publication number
TWI301763B
TWI301763B TW92125445A TW92125445A TWI301763B TW I301763 B TWI301763 B TW I301763B TW 92125445 A TW92125445 A TW 92125445A TW 92125445 A TW92125445 A TW 92125445A TW I301763 B TWI301763 B TW I301763B
Authority
TW
Taiwan
Prior art keywords
tolterodine
release rate
long
dosage form
hours
Prior art date
Application number
TW92125445A
Other languages
English (en)
Chinese (zh)
Other versions
TW200512015A (en
Inventor
yi-zhi Liu
Yu Fang Hu
Yao Kun Huang
Original Assignee
Tty Biopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tty Biopharm Co Ltd filed Critical Tty Biopharm Co Ltd
Priority to TW092125445A priority Critical patent/TW200512015A/zh
Publication of TW200512015A publication Critical patent/TW200512015A/zh
Application granted granted Critical
Publication of TWI301763B publication Critical patent/TWI301763B/zh

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW092125445A 2003-09-16 2003-09-16 Orally controlled-releasing formulation of tolterodine and method of preparation thereof TW200512015A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW092125445A TW200512015A (en) 2003-09-16 2003-09-16 Orally controlled-releasing formulation of tolterodine and method of preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW092125445A TW200512015A (en) 2003-09-16 2003-09-16 Orally controlled-releasing formulation of tolterodine and method of preparation thereof

Publications (2)

Publication Number Publication Date
TW200512015A TW200512015A (en) 2005-04-01
TWI301763B true TWI301763B (pt) 2008-10-11

Family

ID=45070324

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092125445A TW200512015A (en) 2003-09-16 2003-09-16 Orally controlled-releasing formulation of tolterodine and method of preparation thereof

Country Status (1)

Country Link
TW (1) TW200512015A (pt)

Also Published As

Publication number Publication date
TW200512015A (en) 2005-04-01

Similar Documents

Publication Publication Date Title
TWI289063B (en) Preparation with a good disintegrating property
TWI241188B (en) Sertraline salts and sustained-release dosage forms of sertraline
TWI254640B (en) Use of a polymer of acrylic type as a disintegration agent
KR100897890B1 (ko) 티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법
CN101073563B (zh) 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片
AU2010289022B2 (en) New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
JP4744142B2 (ja) ラモトリギンを含む徐放性処方
US10646456B2 (en) Methods of administering amantadine
TW200814992A (en) Stabilized pharmaceutical compositions comprising fesoterodine
CN107205950B (zh) 金刚烷胺组合物的施用方法
TW200404009A (en) High drug load tablet
JPH04501425A (ja) ロラタジン、イブプロフェンおよびプソイドエフェドリンを含む薬剤組成物
CN102908339A (zh) 他喷他多组合物
JP2004534031A (ja) 心臓および循環器疾患の治療および予防を目的とする一日一回の治療のための経口制御放出医薬組成物
JP2002524534A (ja) 非合法使用に適さない交感神経刺激性アミン塩を含んでなる組成物
CN105338970A (zh) 包含他达拉非和坦洛新的药物胶囊复合制剂
TW201110970A (en) Oral dosage formulation containing both immediate-release and sustained-release drugs for treating ng neurodegenerative disorders
CA3072764A1 (en) Amantadine compositions, preparations thereof, and methods of use
Angeletti et al. Tramadol Extended‐Release for the Management of Pain due to Osteoarthritis
JP2005522467A5 (pt)
EP0840598A1 (en) Alkalinizing potassium salt controlled release preparations
TWI301763B (pt)
FR3104438A1 (fr) Formulation pour le bleu de methylene et procede
CN101478965A (zh) 蒿甲醚和本芴醇的高剂量口服药物组合物
CN101129358B (zh) 莫吉司坦缓释片及其制备方法

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees